Clinical Trials on Advanced or Metastatic Solid Tumor in United States
Total 4977 results
-
Cascadian Therapeutics Inc.Completed
-
Gem PharmaceuticalsCompletedAdvanced Solid Tumors - Phase 1 PopulationUnited States
-
AmgenCompletedAdvanced Solid TumorsBelgium, Canada, Australia, United States, Spain, Poland, France, Germany, Japan, United Kingdom
-
Edgewood Oncology Inc.RecruitingMetastatic Breast Cancer | Advanced Solid TumorUnited States
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid TumorsUnited States, Spain, Canada, Norway, Switzerland
-
University of Texas Southwestern Medical CenterCompletedPain | Unspecified Adult Solid Tumor, Protocol Specific | Metastatic CancerUnited States
-
Millennium Pharmaceuticals, Inc.TerminatedAdvanced Malignant Solid TumorsUnited States
-
T3 Pharmaceuticals AGRecruiting
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedAdvanced Solid TumorsSpain, United States, Netherlands, Hungary, Italy, France, Belgium
-
Sumitomo Pharma America, Inc.CompletedCancer | Advanced Solid TumorsUnited States
-
National Cancer Institute (NCI)Active, not recruitingSolid Tumor | Prostate Cancer | Advanced Solid Tumor | Metastatic Prostate Cancer | Prostate NeoplasmUnited States
-
AO Innovation Translation CenterAO Foundation, AO SpineRecruitingMetastatic Spine TumorUnited States, Canada, Hungary, Australia, Germany, Italy, Japan, Netherlands, Singapore, Switzerland
-
Incyte CorporationActive, not recruitingAdvanced Solid TumorsUnited States, Sweden, Netherlands, Norway, Denmark
-
PharmaMarCompletedAdvanced Solid TumorsUnited Kingdom, Switzerland
-
Arcus Biosciences, Inc.Gilead Sciences; Strata OncologyActive, not recruitingAdvanced Solid TumorsUnited States
-
AmgenCompletedAdvanced Solid TumorsUnited States, Belgium, Spain, Australia
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Solid TumorsUnited States, Korea, Republic of, Australia
-
Abion IncRecruitingAdvanced Solid TumorsKorea, Republic of, Taiwan, United States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Incyte CorporationRecruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
Duke UniversityAmerican Cancer Society, Inc.RecruitingPain | Advanced Solid TumorUnited States
-
Duke UniversityIcahn School of Medicine at Mount SinaiCompleted
-
Tianhong LiNational Cancer Institute (NCI); LabyRx Immunologic TherapeuticsRecruitingAdvanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Adenocarcinoma | Advanced Adenocarcinoma | Recurrent AdenocarcinomaUnited States
-
PharmaMarCompletedAdvanced Solid TumorsSpain, United States, Belgium, France, Italy, Switzerland, Germany, Sweden, United Kingdom
-
Eli Lilly and CompanyTerminated
-
Novartis PharmaceuticalsRecruitingAdvanced Solid TumorsSwitzerland, Korea, Republic of, Belgium, Canada, Italy, Spain, Germany, Hong Kong, Hungary, China, Czechia, Taiwan, United States, France, Poland, Thailand, Netherlands
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid Tumors | Pharmacokinetics of 14C-OSI-906United States
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLCRecruitingAdvanced Solid TumorsUnited States, Japan
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Korea, Republic of
-
Relay Therapeutics, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Solid Tumor, Adult | HER2-negative Breast Cancer | Unresectable Solid Tumor | PIK3CA MutationUnited States, Spain, France, Italy
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Germany, Italy, United Kingdom, Belgium, Canada, Korea, Republic of, Taiwan, France
-
Eisai Inc.Completed
-
Vividion Therapeutics, Inc.RecruitingAdvanced Solid TumorsUnited States, Spain
-
Merck Sharp & Dohme LLCTerminatedAdvanced Solid TumorsCanada, United States, Denmark, Israel, Switzerland
-
Eisai Inc.Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Refractory NeoplasmUnited States
-
BayerCompletedAdvanced CEACAM6-expressing Solid TumorsUnited States, Singapore, Canada
-
Turning Point Therapeutics, Inc.Active, not recruitingAdvanced Solid Tumor | Metastatic Solid Tumors | MET Gene AlterationsUnited States, France, Korea, Democratic People's Republic of, Korea, Republic of, Spain
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
PfizerCompletedAdvanced Solid TumorsUnited States, United Kingdom
-
Altor BioScienceNational Cancer Institute (NCI)CompletedAdvanced Solid TumorsUnited States
-
Hoffmann-La RocheRecruitingAdvanced Solid TumorsUnited States
-
AmgenRecruitingAdvanced Solid TumorsUnited States, Korea, Republic of, Spain, Australia, Germany, France, Japan, Canada
-
Johnson & Johnson Enterprise Innovation Inc.RecruitingAdvanced Solid TumorsUnited States
-
PharmaMarCompletedMajor Advanced Solid Tumors Other Than ColorectalUnited States
-
Regeneron PharmaceuticalsRecruitingAdvanced Solid TumorsUnited States, Turkey
-
MedImmune LLCCompletedSelect Advanced Solid TumorsUnited States, France, Netherlands
-
Replimune Inc.Bristol-Myers SquibbActive, not recruitingAdvanced Solid TumorUnited States, United Kingdom, Spain, Greece, France
-
Bristol-Myers SquibbActive, not recruitingAdvanced Solid TumorsCanada, United States, Spain, France, Switzerland
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Metastatic CancerUnited States
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Korea, Republic of, Taiwan, Portugal, Spain, United Kingdom, Italy, Canada, Japan